Glucagon-like peptide-1 receptor agonists, selection within the class. The rational combination of insulin glargine 100 + lixisenatide

by M. V. Martjanova, A. Yu. Babenko
Published 2020-05-01

Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia

by D. A. Lebedev, A. Yu. Babenko
Published 2018-09-01

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor

by D. A. Lebedev, A. A. Mosikian, A. Yu. Babenko
Published 2020-10-01

GLYCEMIC AND NON-GLYCEMIC EFFECTS OF EXENATIDE IN PATIENTS WITH DIABETES MELLITUS OF TYPE 2 (DM2) WITH MYOCARDIAL INFARCTION

by A. Yu. BABENKO, V. A. ZYKOV, E. N. GRINEVA
Published 2016-12-01

Main results of the ADVANCE study: clinical interpretation for endocrinologists

by Alsu Gafurovna Zalevskya, A Yu Babenko, A R Volkova
Published 2009-06-01

Biomarkers associated with atherogenesis: current status and promising areas

by M. A. Magruk, A. A. Mosikyan, A. Yu. Babenko
Published 2019-12-01

Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis

by D. A. Lebedev, E. A. Lyasnikova, E. Yu Vasilyeva, A. Yu Babenko, E. V. Shlyakhto
Published 2020-01-01

ASSESSMENT OF SODIUM-GLUCOSE CO-TRANSPORTER INHIBITOR IN COMBINATION WITH INSULIN ON METABOLIC PARAMETERS AND RENAL MORPHOFUNCTIONAL CHANGES IN RATS WITH EXPERIMENTAL DIABETES MELL...

by D. A. Lebedev, N. P. Likhonosov, Т. P. Tuchina, V. K. Bayrasheva, A. Yu. Babenko
Published 2017-11-01

Polymorphism of S19W of apolipoprotein A5gene in patients with type 2 diabetes mellitus - connection with metabolic parameters and triglyceride levels

by S. A. Skoryukova, M. V. Kim, A. A. Bystrova, A. Yu. Babenko, E. I. Baranova, S. N. Pchelina
Published 2015-06-01

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes

by D. A. Lebedev, E. A. Lyasnikova, A. A. Vasilyeva, E. Yu. Vasilyeva, A. Yu. Babenko, E. V. Shlyakhto
Published 2020-11-01

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered qu...

by E. A. Lyasnikova, A. A. Kuular, A. V. Pavlovskaya, A. N. Vlasenko, A. V. Kozlenok, A. Yu. Babenko, M. Yu. Sitnikova, E. V. Shlyakhto
Published 2021-07-01

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES

by M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov
Published 2016-05-01